Delivery Order SPE2DB20D2001-SPE2DB25FPNUY
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $14,629.81 to AmerisourceBergen Drug Corp for the supply of Dupixent 300 mg/2 mL pen auto-injectors. This non-competed delivery order, issued on August 22, 2025, with an ultimate completion date of August 25, 2025, represents a firm fixed-price transaction for pharmaceutical supply to support federal medical procurement needs. The work will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order valued at $19,245.49 to AmerisourceBergen Drug Corp for the supply of Dupixent 300 mg/2 mL pen auto-injectors on July 14, 2025, with completion scheduled for July 15, 2025. This non-competitive delivery order utilizes firm fixed pricing and represents a continuation of the vendor's pharmaceutical supply services to federal medical procurement. The place of performance is AmerisourceBergen's corporate headquarters in Conshohocken,...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 6, 2025, for the supply of Dupixent 300 mg/2 ml pen auto-injectors valued at $15,382.72. This non-set-aside, competitively awarded delivery order represents a firm fixed price contract with an ultimate completion date of August 7, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for...
- The Defense Logistics Agency awarded a delivery order valued at $91,927.71 to AmerisourceBergen Drug Corp for the supply of Dupixent 300 mg/2 ml pen auto-injectors on September 23, 2025, with completion targeted for September 24, 2025. This competitively awarded, firm fixed-price contract represents a single delivery order with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor supporting federal medical...
- The Defense Logistics Agency awarded a $27,227.34 delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Dupixent 300 mg/2 mL pen auto-injectors. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and is scheduled for completion by August 5, 2025. AmerisourceBergen, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. The delivery order serves the Defense...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $6,653.11 for Dupixent 300 mg/2 ml pen auto-injectors on August 4, 2025, with an ultimate completion date of August 5, 2025. This is a firm fixed-price delivery order with no set-aside designation, issued competitively under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), an extensive $999.999 billion pharmaceutical support vehicle running through...
- The Defense Logistics Agency awarded a $27,537.91 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Dupixent 300 mg/2 mL pen injectors on April 23, 2025, with completion scheduled for April 24, 2025. This non-compete delivery order represents a pharmaceutical supply transaction under the company's existing contract vehicle with DLA. The product will be delivered to AmerisourceBergen's corporate headquarters location in Conshohocken, Pennsylvania, where the company maintains...
- The Defense Logistics Agency awarded a delivery order valued at $36,944.08 to AmerisourceBergen Drug Corp for Dupixent 300 mg/2 ml pen injectors on August 14, 2025, with completion scheduled for August 15, 2025. This firm fixed price, competitively awarded delivery order represents a direct fulfillment under the company's existing pharmaceutical supply agreement with DLA. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for...
- The Defense Logistics Agency awarded a $11,972.71 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 24, 2025, for the supply of Dupixent 300 mg/2 ml pen injectors (2 ml units). This is a non-set-aside competitive award with an ultimate completion date of September 25, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract with DLA...
- The Defense Logistics Agency awarded a $21,852.02 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Dupixent 300 mg/2 mL pen injectors with an ultimate completion date of August 19, 2025. This non-set-aside, competitively awarded contract represents a single delivery order fulfilling federal pharmaceutical procurement requirements. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a major pharmaceutical distributor and critical...
- SPE2DB20D2001Indefinite Delivery Contract
- SPE2DB20D2001-SPE2DB25FPNUYDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $39,400.27 to AmerisourceBergen Drug Corp for the supply of Dupixent 300 mg/2 mL pen auto-injectors on September 25, 2025, with completion scheduled for September 26, 2025. This is a firm fixed-price, non-set-aside contract for pharmaceutical delivery to support federal medical supply requirements. The place of performance is listed as the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which carries a total value of $999,999,999.00 and extends through December 2026. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical vendor for federal military and veteran healthcare procurement. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of medications, vaccines, medical devices, and specialized healthcare commodities to support defense health programs worldwide, including the Defense Health Agency and U.S. Coast Guard. The company's federal contracting demonstrates consistent capability in competitively awarded pharmaceutical supply, with delivery orders ranging from under $100 to over $45,000, reflecting its versatility in fulfilling federal medical supply needs across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $39.4k | 9/25/25 |